Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Up-regulation of KISS1 as a novel target of Let-7i in melanoma serves as a potential suppressor of migration and proliferation in vitro.
Alkafaji HA, Raji A, Rahman HS, Zekiy AO, Adili A, Jalili M, Hojjatipour T, Cid-Arregui A, Shomali N, Tarzi S, Tamjidifar R, Heshmati R, Marofi F, Akbari M, Hasanzadeh A, Deljavanghodrati M, Jarahian M, Sandoghchian Shotorbani S. Alkafaji HA, et al. Among authors: adili a. J Cell Mol Med. 2021 Jul;25(14):6864-6873. doi: 10.1111/jcmm.16695. Epub 2021 Jun 6. J Cell Mol Med. 2021. PMID: 34096173 Free PMC article.
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E. Naimi A, et al. Among authors: adili a. Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y. Cell Commun Signal. 2022. PMID: 35392976 Free PMC article. Review.
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
Shojaei Baghini S, Gardanova ZR, Abadi SAH, Zaman BA, İlhan A, Shomali N, Adili A, Moghaddar R, Yaseri AF. Shojaei Baghini S, et al. Among authors: adili a. Cell Mol Biol Lett. 2022 May 4;27(1):35. doi: 10.1186/s11658-022-00336-6. Cell Mol Biol Lett. 2022. PMID: 35508982 Free PMC article. Review.
Anastasis: cell recovery mechanisms and potential role in cancer.
Mohammed RN, Khosravi M, Rahman HS, Adili A, Kamali N, Soloshenkov PP, Thangavelu L, Saeedi H, Shomali N, Tamjidifar R, Isazadeh A, Aslaminabad R, Akbari M. Mohammed RN, et al. Among authors: adili a. Cell Commun Signal. 2022 Jun 3;20(1):81. doi: 10.1186/s12964-022-00880-w. Cell Commun Signal. 2022. PMID: 35659306 Free PMC article. Review.
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.
Sajjadi-Dokht M, Merza Mohamad TA, Sulaiman Rahman H, Suliman Maashi M, Danshina S, Shomali N, Solali S, Marofi F, Zeinalzadeh E, Akbari M, Adili A, Aslaminabad R, Farshdousti Hagh M, Jarahian M. Sajjadi-Dokht M, et al. Among authors: adili a. Genes Dis. 2021 Dec 3;9(4):849-867. doi: 10.1016/j.gendis.2021.10.009. eCollection 2022 Jul. Genes Dis. 2021. PMID: 35685482 Free PMC article. Review.
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. Mohammed RN, et al. Among authors: adili a. Cell Commun Signal. 2022 Jun 15;20(1):90. doi: 10.1186/s12964-022-00913-4. Cell Commun Signal. 2022. PMID: 35705949 Free PMC article. No abstract available.
141 results